Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Kamar

Showing results (1-10 of 125) with videos related to

Pageof 13
Sort By:
Nephrologie & Therapeutique|September 26, 2008
[Monitoring of calcineurin inhibitors induced-nephrotoxicity]N Kamar, L Rostaing
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 11, 2011
No reactivation of hepatitis e virus after kidney retransplantationN Kamar, J Izopet, L Rostaing
Kidney International|March 4, 2006
Treatment of hepatitis C-virus-related glomerulonephritisN Kamar, L Rostaing, L Alric
Nephrologie|June 20, 2003
[Hepatitis C infection among patients receiving hemodialysis]N Kamar, J Izopet, L Rostaing
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 6, 2016
When Should Ribavirin Be Started to Treat Hepatitis E Virus Infection in Transplant Patients?N Kamar, O Marion, J Izopet
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 13, 2009
Incidence of JC-virus replication after rituximab therapy in solid-organ transplant patientsN Kamar, C Mengelle, L Rostaing
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 23, 2007
Influence of rituximab therapy on hepatitis C virus RNA concentration in kidney-transplant patientsN Kamar, K Sandres-Sauné, L Rostaing
Contributions to Nephrology|February 8, 2012
Hepatitis C and renal disease: epidemiology, diagnosis, pathogenesis and therapyJose M Morales, N Kamar, L Rostaing
Clinical and Experimental Immunology|December 24, 2019
T cell reconstitution after lymphocyte depletion features a different pattern of inhibitory receptor expression in ABO- versus HLA-incompatible kidney transplant recipientsA Del Bello, N Kamar, E Treiner
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|February 22, 2011
Viral infections after kidney transplantationL Rostaing, H Wéclawiak, C Mengelle, et al.
Pageof 13

Showing results (1-10 of 125) with videos related to

Sort By:
Pageof 13
Nephrologie & Therapeutique|September 26, 2008
[Monitoring of calcineurin inhibitors induced-nephrotoxicity]N Kamar, L Rostaing
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 11, 2011
No reactivation of hepatitis e virus after kidney retransplantationN Kamar, J Izopet, L Rostaing
Kidney International|March 4, 2006
Treatment of hepatitis C-virus-related glomerulonephritisN Kamar, L Rostaing, L Alric
Nephrologie|June 20, 2003
[Hepatitis C infection among patients receiving hemodialysis]N Kamar, J Izopet, L Rostaing
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 6, 2016
When Should Ribavirin Be Started to Treat Hepatitis E Virus Infection in Transplant Patients?N Kamar, O Marion, J Izopet
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 13, 2009
Incidence of JC-virus replication after rituximab therapy in solid-organ transplant patientsN Kamar, C Mengelle, L Rostaing
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 23, 2007
Influence of rituximab therapy on hepatitis C virus RNA concentration in kidney-transplant patientsN Kamar, K Sandres-Sauné, L Rostaing
Contributions to Nephrology|February 8, 2012
Hepatitis C and renal disease: epidemiology, diagnosis, pathogenesis and therapyJose M Morales, N Kamar, L Rostaing
Clinical and Experimental Immunology|December 24, 2019
T cell reconstitution after lymphocyte depletion features a different pattern of inhibitory receptor expression in ABO- versus HLA-incompatible kidney transplant recipientsA Del Bello, N Kamar, E Treiner
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|February 22, 2011
Viral infections after kidney transplantationL Rostaing, H Wéclawiak, C Mengelle, et al.
Pageof 13